Interpace Biosciences Inc (IDXG)

Sector:
HEALTH CARE
Industry:
HEALTH CARE SERVICES
SIC:
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
CEO:
Jack E. Stover
Employees:
89
MORRIS CORPORATE CENTER 1,, BUILDING C, 300 INTERPACE PARKWAY, PARSIPPANY, NJ 07054
412-224-6100

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

Interpace Diagnostics Group, Inc. provides commercialization services to biopharmaceutical companies. It focuses on developing and commercializing molecular diagnostic tests, leveraging the latest technology and personalized medicine for patient diagnosis and management. The company offers commercialized molecular tests which include PancraGen, ThyGenX, and ThyraMIR. PancraGen for the diagnosis and prognosis of pancreatic cancer from pancreatic cysts; ThyGenX, for the diagnosis of thyroid cancer from thyroid nodules utilizing a next generation sequencing assay and ThyraMIR, for the diagnosis of thyroid cancer from thyroid nodules utilizing a proprietary gene expression assay. The company was founded by John P. Dugan in 1987 and is headquartered in Parsippany, NJ.

Data derived from most recent annual or quarterly report
Market Cap 16.087 Million Shares Outstanding4.104 Million Avg 30-day Volume 341.698 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-2.15
Price to Revenue31.4986 Debt to Equity0.0 EBITDA-33.382 Million
Price to Book Value2.6665 Operating Margin-358.9646 Enterprise Value217.946 Million
Current Ratio7.516 EPS Growth0.721 Quick Ratio6.953
1 Yr BETA 52-week High/Low 0.0 / Profit Margin-363.205
Operating Cash Flow Growth-45.7097 Altman Z-Score13.1882 Free Cash Flow to Firm -55.319 Million
View SEC Filings from IDXG instead.

View recent insider trading info

Funds Holding IDXG (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding IDXG BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

BURNELL THOMAS W. PRESIDENT & CEO

  • Officer
  • Director
235,855 2021-05-21 3

FREEBURG THOMAS JOHN CHIEF FINANCIAL OFFICER

  • Officer
102,000 2021-03-10 1

KAMIN PETER

  • 10% Owner
781,956 2021-02-26 2

GORMAN ROBERT J.

  • Director
18,759 2021-01-29 1

STOVER JACK E

  • FORMER OFFICER AND DIRECTOR
No longer subject to file 2020-12-01 1

EARLY JAMES

  • FORMER CHIEF FINANCIAL OFFICER
No longer subject to file 2020-07-29 0

SULLIVAN STEPHEN J

  • Director
0 2020-07-09 0

KEEGAN JOSEPH D

  • Director
0 2020-07-09 0

ROCCA FORTUNATO R.

  • Director
0 2020-07-09 0

LAMPE-ONNERUD CHRISTINA

  • Director
2,391 2020-02-01 0

MARCET PABLO

  • Director
9,391 2020-02-01 0

KNECHTEL FRED S. CHIEF FINANCIAL OFFICER

  • Officer
0 2020-01-29 0

RICHARD GREGORY CHIEF COMMERICAL OFFICER

  • Officer
No longer subject to file 2020-01-22 0

MCCARTHY LAURENCE

  • Director
No longer subject to file 2020-01-15 0

1315 CAPITAL II, L.P.

  • 10% Owner
0 2020-01-15 0

AMPERSAND 2018 LIMITED PARTNERSHIP

  • 10% Owner
0 2020-01-15 0

LEV ERIC B.

  • Director
0 2020-01-15 0

CHAN EDWARD

  • Director
0 2020-01-15 0

SCHNOLL-SUSSMAN FELICE

  • Director
4,800 2018-03-07 0

NASGOVITZ WILLIAM J

HEARTLAND ADVISORS INC

  • NO LONGER SUBJECT TO SEC. 16NO LONGER SUBJECT TO SEC. 16
No longer subject to file 2016-10-14 0

KRISHNAMURTI NAT INTERIM CFO

  • Officer
8,793 2016-03-01 0

GLORIKIAN HARRY

  • Director
127,696 2016-02-03 0

MIAO GRAHAM G CFO

  • Officer
354,724 2015-12-28 0

MELILLO GERALD R JR PRESIDENT, SALES SERVICES

  • Officer
267,121 2015-11-25 0

RATNAM KAPILA

  • Director
0 2015-10-30 0

FEDERSPIEL JOHN

  • Director
166,665 2015-06-03 0

DREISMANN HEINER

  • Director
66,263 2015-06-03 0

BELLE GERALD P.

  • Director
275,617 2015-06-03 0

LURKER NANCY CEO

  • Officer
  • Director
1,404,998 2015-03-05 0

SMITH JEFFREY EDWARD VP OF CORPORATE DEVELOPMENT

  • Officer
734,388 2014-11-07 0

CLIMACO JOHN M

  • Director
33,122 2014-06-04 0

LUBATKIN VERONICA

  • Director
98,206 2013-06-04 0

SAITTA JO ANN SVP AND CIO, GM GROUP DCA

  • Officer
109,844 2013-03-01 0

RYAN FRANK J

  • Director
80,850 2011-05-31 0

MICALI RICHARD P SENIOR VP, SALES SERVICES

  • Officer
55,735 2011-03-03 0

KERR DAVID E SENIOR VP BUSINESS DEVELOPMENT

  • Officer
39,769 2011-03-03 0

DRAZNER HOWARD SVP,BUS. DEV MEDICAL EDUCATION

  • Officer
53,249 2010-11-29 0

LIKOFF ROBERT OWEN CO-CEO, GROUP DCA

  • Officer
0 2010-11-03 0

DAVIS JACK CO-CEO, GROUP DCA

  • Officer
0 2010-11-03 0

VECSI JAN MARTENS

  • Director
87,839 2010-06-03 0

PIETRUSKI JOHN M

  • Director
42,688 2009-06-04 0

CURTI JOSEPH I

  • Director
38,688 2009-06-04 0

TILLES PETER PRESIDENT, TVG

  • Officer
11,966 2009-04-01 0

FARRELL JAMES G. VP, CORPORATE CONTROLLER

  • Officer
13,843 2008-11-18 0

MARQUARD MICHAEL CEO

  • Officer
142,194 2008-06-11 0

MCCARTHY NANCY EVP, HUMAN RESOURCES

  • Officer
35,871 2008-02-27 0

CONNOLLY KEVIN EVP, MARKETING SERVICES

  • Officer
51,893 2008-02-27 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
INTERPACE BIOSCIENCES INC IDXG 2021-10-15 22:15:04 UTC -10.3249 10.3949 80000
INTERPACE BIOSCIENCES INC IDXG 2021-10-15 21:45:03 UTC -10.3255 10.3955 80000
INTERPACE BIOSCIENCES INC IDXG 2021-10-15 21:15:03 UTC -10.3255 10.3955 80000
INTERPACE BIOSCIENCES INC IDXG 2021-10-15 20:45:03 UTC -10.3255 10.3955 80000
INTERPACE BIOSCIENCES INC IDXG 2021-10-15 20:15:03 UTC -10.3255 10.3955 80000
INTERPACE BIOSCIENCES INC IDXG 2021-10-15 19:45:03 UTC -10.3255 10.3955 80000
INTERPACE BIOSCIENCES INC IDXG 2021-10-15 19:15:04 UTC -10.3255 10.3955 80000
INTERPACE BIOSCIENCES INC IDXG 2021-10-15 18:45:03 UTC -10.3255 10.3955 80000
INTERPACE BIOSCIENCES INC IDXG 2021-10-15 18:15:03 UTC -10.3255 10.3955 80000
INTERPACE BIOSCIENCES INC IDXG 2021-10-15 17:45:03 UTC -10.3255 10.3955 75000
INTERPACE BIOSCIENCES INC IDXG 2021-10-15 17:15:03 UTC -10.3255 10.3955 75000
INTERPACE BIOSCIENCES INC IDXG 2021-10-15 16:45:03 UTC -10.3249 10.3949 75000
INTERPACE BIOSCIENCES INC IDXG 2021-10-15 16:15:03 UTC -10.3249 10.3949 75000
INTERPACE BIOSCIENCES INC IDXG 2021-10-15 15:45:03 UTC -10.3249 10.3949 75000
INTERPACE BIOSCIENCES INC IDXG 2021-10-15 15:15:03 UTC -10.3249 10.3949 75000
INTERPACE BIOSCIENCES INC IDXG 2021-10-15 14:45:02 UTC -10.3249 10.3949 25000
INTERPACE BIOSCIENCES INC IDXG 2021-10-15 14:15:03 UTC -10.3249 10.3949 25000
INTERPACE BIOSCIENCES INC IDXG 2021-10-15 13:45:03 UTC -10.3249 10.3949 25000
INTERPACE BIOSCIENCES INC IDXG 2021-10-15 13:15:03 UTC -10.3249 10.3949 25000
INTERPACE BIOSCIENCES INC IDXG 2021-10-15 12:45:03 UTC -10.3249 10.3949 25000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments